Cim LLC Cuts Stock Holdings in Doximity, Inc. $DOCS

Key Points

• Cim LLC reduced its holdings in Doximity, Inc. by 18.4%, now owning 57,299 shares worth approximately $3.33 million.
• Doximity reported earnings of $0.36 EPS for the last quarter, exceeding analysts' estimates of $0.31, with a revenue increase of 15.2% year-over-year.
• Various research firms have set new target prices for Doximity, with Goldman Sachs at $50.00 and Robert W. Baird at $80.00, reflecting a range of ratings from "Buy" to "Neutral."

Cim LLC lessened its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 18.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,299 shares of the company's stock after selling 12,943 shares during the quarter. Cim LLC's holdings in Doximity were worth $3,325,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in DOCS. Strs Ohio acquired a new position in shares of Doximity during the first quarter valued at about $665,000. Focus Partners Wealth bought a new position in Doximity in the 1st quarter valued at about $283,000. Plato Investment Management Ltd lifted its position in Doximity by 48.0% in the 1st quarter. Plato Investment Management Ltd now owns 5,731 shares of the company's stock valued at $336,000 after acquiring an additional 1,860 shares in the last quarter. Bayforest Capital Ltd boosted its stake in Doximity by 162.1% during the 1st quarter. Bayforest Capital Ltd now owns 10,614 shares of the company's stock valued at $616,000 after purchasing an additional 6,565 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Doximity by 130.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company's stock worth $114,133,000 after purchasing an additional 1,113,076 shares in the last quarter. 87.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DOCS. Canaccord Genuity Group increased their price objective on Doximity from $50.00 to $59.00 and gave the stock a "hold" rating in a research note on Friday, August 8th. Bank of America increased their price target on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. Raymond James Financial set a $75.00 price objective on Doximity in a research note on Wednesday, September 10th. Needham & Company LLC raised their price objective on Doximity from $67.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Finally, Robert W. Baird raised their price objective on Doximity from $75.00 to $80.00 and gave the company an "outperform" rating in a research note on Thursday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have given a Hold rating to the company's stock. According to MarketBeat.com, Doximity currently has a consensus rating of "Moderate Buy" and a consensus target price of $67.00.

Doximity Stock Down 0.0%

Doximity stock traded down $0.03 during midday trading on Wednesday, hitting $72.05. 262,003 shares of the stock were exchanged, compared to its average volume of 2,204,432. Doximity, Inc. has a 52-week low of $39.62 and a 52-week high of $85.21. The stock has a market capitalization of $13.50 billion, a price-to-earnings ratio of 72.05, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37. The business's 50-day moving average price is $64.05 and its 200-day moving average price is $59.87.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the previous year, the firm earned $0.28 EPS. The company's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, sell-side analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Doximity news, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $70.50, for a total value of $352,500.00. Following the sale, the director owned 19,839 shares of the company's stock, valued at approximately $1,398,649.50. The trade was a 20.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the sale, the director directly owned 16,618 shares in the company, valued at approximately $948,721.62. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 37,000 shares of company stock valued at $2,281,880. Company insiders own 31.30% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.